Screening for vancomycin-resistant enterococci with Xpert® : diagnostic accuracy and impact on infection control decision making.

Vancomycin-resistant enterococci (VRE) are increasingly important nosocomial pathogens and screening for colonization status is a mainstay in infection control. We implemented PCR-based screening during -positive outbreaks in four university hospitals in Copenhagen, Denmark. Xpert was performed directly on rectal swabs and the PCR result was used to guide infection control measures. Concurrently, all samples were selectively cultured including an overnight enrichment step. Diagnostic accuracy was calculated as well as turnaround time and the impact of the earlier available PCR results on infection control decision making. In all, 1110 samples were analysed. The PCR positivity rate was 13.8% and culture positivity rate was 15.2%. The diagnostic accuracy of the part of the assay was high with a sensitivity of 87.1%, a specificity of 99.7%, and positive and negative predictive values of 98.0% and 97.7%, respectively. The PCR had a considerably lower specificity of 77.6% and a positive predictive value of 0.4%. In 1067 (96.1%) samples, PCR results were reported within 1 day, whereas median culture turnaround time was 3 days. The saving of time to available results corresponded to 141 saved isolation days and 292 saved transmission risk days. False-negative or false-positive PCR results led to six additional transmission risk days and 13 additional isolation days, respectively. The PCR had high diagnostic accuracy and the prompt availability of results gave a considerable benefit for infection control decision making.